NCT01015625 2024-08-19
POSYTIVE
Austrian Breast & Colorectal Cancer Study Group
Phase NA Completed
Clinical Trials
3 trialsNCT03070002 2018-11-20
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
Northwestern University
Phase 2 Terminated
NCT00429182 2013-04-10
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed